Intern - Industrial Hygienist - Davie, FL jobs in United States
cer-icon
Apply on Employer Site
company-logo

Teva Pharmaceuticals · 12 hours ago

Intern - Industrial Hygienist - Davie, FL

positionDavie, FL
timeInternship
remoteOnsite
seniorityIntern

Teva Pharmaceuticals is a leading innovative biopharmaceutical company dedicated to addressing patients’ needs. The intern will gain insight into the EHS&S department and be involved in meaningful projects while supported by mentors and experienced colleagues.

BiopharmaHealth CareMedicalPharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

During the 12 week program, you will gain in-depth insight into the EHS&S department
Supported by a mentor and experienced colleagues, you will be directly involved in our daily business and be assigned tasks within diverse projects
You will also play an important role in the development of concepts and initiatives within the TGO business unit

Qualification

Occupational healthIndustrial hygieneEHS&S knowledgeCollaborationCreativity

Required

Currently enrolled in undergraduate or graduate program in the area of occupational health or related field
Fundamental understanding and experience in industrial hygiene
Willing and able to work a 40-hour work week for 12 weeks onsite in Davie, FL

Company

Teva Pharmaceuticals

twittertwittertwitter
Glassdoor3.7
company-logo
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
dateFounded in 1901
location
Tel Aviv, Tel Aviv, ISR
people-size10001+ employees
web-link
https://www.tevapharm.com

H1B Sponsorship

Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)

Funding

Current Stage
Public Company
Total Funding
$5.51B
Key Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M

Leadership Team

leader-logo
Dipankar Bhattacharjee
President & CEO: Generics Europe
linkedin
leader-logo
Richard Francis
President and Chief Executive Officer
linkedin

Recent News

FiercePharma
JPM26: What’s in a biopharma? CEO says Teva has the goods
2026-01-17
Globes
Teva collaborates on skin disease treatment, releases targets
2026-01-14
Benzinga.com
Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial
2026-01-14
Company data provided by crunchbase